Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13509: Variant p.Arg62Gln

Tubulin beta-3 chain
Gene: TUBB3
Feedback?
Variant information Variant position: help 62 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glutamine (Q) at position 62 (R62Q, p.Arg62Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In CFEOM3A; affects heterodimers formation; results in increased stability and reduced dynamics of microtubules. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 62 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 450 The length of the canonical sequence.
Location on the sequence: help LQLERISVYYNEASSHKYVP R AILVDLEPGTMDSVRSGAFG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 450 Tubulin beta-3 chain
Binding site 69 – 69
Binding site 69 – 69
Alternative sequence 1 – 72 Missing. In isoform 2.



Literature citations
Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance.
Tischfield M.A.; Baris H.N.; Wu C.; Rudolph G.; Van Maldergem L.; He W.; Chan W.M.; Andrews C.; Demer J.L.; Robertson R.L.; Mackey D.A.; Ruddle J.B.; Bird T.D.; Gottlob I.; Pieh C.; Traboulsi E.I.; Pomeroy S.L.; Hunter D.G.; Soul J.S.; Newlin A.; Sabol L.J.; Doherty E.J.; de Uzcategui C.E.; de Uzcategui N.; Collins M.L.; Sener E.C.; Wabbels B.; Hellebrand H.; Meitinger T.; de Berardinis T.; Magli A.; Schiavi C.; Pastore-Trossello M.; Koc F.; Wong A.M.; Levin A.V.; Geraghty M.T.; Descartes M.; Flaherty M.; Jamieson R.V.; Moller H.U.; Meuthen I.; Callen D.F.; Kerwin J.; Lindsay S.; Meindl A.; Gupta M.L. Jr.; Pellman D.; Engle E.C.;
Cell 140:74-87(2010)
Cited for: FUNCTION; VARIANTS CFEOM3A GLN-62; CYS-262; HIS-262; THR-302; CYS-380; LYS-410; HIS-417 AND ASN-417; CHARACTERIZATION OF VARIANTS CFEOM3A GLN-62; CYS-262; HIS-262; THR-302; CYS-380 AND LYS-410;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.